ABLi Therapeutics has reported coordinated changes across 11 biomarkers linked [...]

The EMA’s CHMP has recommended approval of NEZGLYAL for boys [...]

Skyhawk Therapeutics has expanded its global pivotal Phase 2/3 clinical [...]

ProMIS Neurosciences has reported the first human evidence that its [...]

New Phase 1 data show Vandria’s VNA-318 reaches the human [...]

TRIMTECH Therapeutics has secured an additional $14 million in seed [...]

  Neurizon has entered a long-term supply agreement with Elanco [...]

Skyhawk Therapeutics has reported encouraging 12-month results from its ongoing [...]

insitro and Bristol Myers Squibb have expanded their ALS collaboration [...]

A gene therapy developed by uniQure appears to slow progression [...]